News
10m
Amgen's late-stage weight-loss drug MariTide is getting ready to enter the final stages of testing as the company enrolls its ...
MicroStrategy MSTR, doing business as “Strategy,” shares closed at $369.70 on Friday, 32% below the 52-week high of $543 it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback